Analyzing Rennova Health (OTCMKTS:RNVA) & Nyxoah (NASDAQ:NYXH)

Rennova Health (OTCMKTS:RNVA) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Volatility & Risk

Rennova Health has a beta of 22.86, indicating that its share price is 2,186% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500.

Profitability

This table compares Rennova Health and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rennova Health	N/A	N/A	N/A
Nyxoah	-884.69%	-128.85%	-80.78%

Earnings and Valuation

This table compares Rennova Health and Nyxoah”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A
Nyxoah	$11.33 million	9.26	-$64.10 million	($2.49)	-1.24

Rennova Health has higher revenue and earnings than Nyxoah.

Analyst Ratings

This is a summary of current ratings and recommmendations for Rennova Health and Nyxoah, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rennova Health	0	0	0	0	0.00
Nyxoah	1	0	3	1	2.80

Nyxoah has a consensus price target of $11.33, suggesting a potential upside of 267.97%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than Rennova Health.

Summary

Rennova Health beats Nyxoah on 6 of the 10 factors compared between the two stocks.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.